Xybion announces a major biotechnology company licenses Pristima for early discovery pathology data management
(1888PressRelease) Xybion Corporation announced that its Pristima Preclinical Software suite has been selected as the primary preclinical platform for early-stage drug discovery pathology data management by a Top-5 global biotech firm. CEDAR KNOLLS, NJ: Xybion Corporation announced that its Pristima Preclinical Software suite has been selected as the primary preclinical platform for early-stage drug discovery …